Agilon Health, Inc.
AGL · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $426,899 | $951,823 | $1,788,013 | $782,884 |
| - Cash | $171,684 | $171,416 | $136,941 | $188,231 |
| + Debt | $34,966 | $41,373 | $42,019 | $41,503 |
| Enterprise Value | $290,181 | $821,780 | $1,693,091 | $636,156 |
| Revenue | $1,435,321 | $1,394,982 | $1,532,782 | $1,522,486 |
| % Growth | 2.9% | -9% | 0.7% | – |
| Gross Profit | -$75,076 | -$52,427 | $50,722 | -$38,255 |
| % Margin | -5.2% | -3.8% | 3.3% | -2.5% |
| EBITDA | -$101,270 | -$95,417 | $6,699 | -$96,605 |
| % Margin | -7.1% | -6.8% | 0.4% | -6.3% |
| Net Income | -$110,207 | -$104,370 | $12,112 | -$105,790 |
| % Margin | -7.7% | -7.5% | 0.8% | -6.9% |
| EPS Diluted | -0.266 | -0.25 | 0.03 | -0.26 |
| % Growth | -6.4% | -933.3% | 111.5% | – |
| Operating Cash Flow | -$18,154 | -$35,085 | -$31,987 | $16,419 |
| Capital Expenditures | -$3,175 | -$3,250 | -$10,883 | -$12,423 |
| Free Cash Flow | -$21,329 | -$38,335 | -$42,870 | $3,996 |